ArticleJournal of medicinal chemistry2023

Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer.

Emilio L Cárdenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.